Figure legends
Figure 1. Characteristic analysis of AE reports in the FAERS and
VigiAccess databases.
Figure 2. The ROR(A) and PRR(B) disproportionality analysis of signals
at PTs level associated with pirfenidone in the FAERS database. ROR,
reporting odds ratio; PRR, proportional reporting ratio; PTs, preferred
terms; FAERS, Food and Drug Administration Adverse Event Reporting
System; 95% CI, 95% credibility interval.
Figure 3. The ROR(A) and PRR(B) disproportionality analysis of signals
at PTs level associated with nintedanib in the FAERS database. ROR,
reporting odds ratio; PRR, proportional reporting ratio; PTs, preferred
terms; FAERS, Food and Drug Administration Adverse Event Reporting
System; 95% CI, 95% credibility interval.